Influence of Extracellular RNAs, Released by Rheumatoid Arthritis Synovial Fibroblasts, on Their Adhesive and Invasive Properties. 2016

Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
Department of Internal Medicine and Rheumatology, Justus Liebig University Giessen, Kerckhoff Clinic, 61231 Bad Nauheim, Germany;

Extracellular RNA (exRNA) has been characterized as a molecular alarm signal upon cellular stress or tissue injury and to exert biological functions as a proinflammatory, prothrombotic, and vessel permeability-regulating factor. In this study, we investigated the contribution of exRNA and its antagonist RNase1 in a chronic inflammatory joint disease, rheumatoid arthritis (RA). Upon immunohistochemical inspection of RA, osteoarthritis (OA), and psoriatic arthritis synovium, exRNA was detectable only in the RA synovial lining layer, whereas extracellular DNA was detectable in various areas of synovial tissue. In vitro, exRNA (150-5000 nt) was released by RA synovial fibroblasts (RASF) under hypoxic conditions but not under normoxia or TNF-α treatment. RNase activity was increased in synovial fluid from RA and OA patients compared with psoriatic arthritis patients, whereas RNase activity of RASF and OASF cultures was not altered by hypoxia. Reduction of exRNA by RNase1 treatment decreased adhesion of RASF to cartilage, but it had no influence on their cell proliferation or adhesion to endothelial cells. In vivo, treatment with RNase1 reduced RASF invasion into coimplanted cartilage in the SCID mouse model of RA. We also analyzed the expression of neuropilins in synovial tissue and SF, as they may interact with vascular endothelial growth factor signaling and exRNA. The data support the concepts that the exRNA/RNase1 system participates in RA pathophysiology and that RASF are influenced by exRNA in a prodestructive manner.

UI MeSH Term Description Entries
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005110 Extracellular Space Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall. Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated

Related Publications

Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
January 2010, Molecular medicine (Cambridge, Mass.),
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
October 2010, Trends in molecular medicine,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
September 2005, Arthritis and rheumatism,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
January 2019, Frontiers in immunology,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
January 2015, Current pharmaceutical design,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
June 1995, Annals of the rheumatic diseases,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
January 2019, Zhonghua nei ke za zhi,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
March 1998, The American journal of pathology,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
May 2009, Nature reviews. Rheumatology,
Birgit Zimmermann-Geller, and Sina Köppert, and Silvia Fischer, and Hector A Cabrera-Fuentes, and Stephanie Lefèvre, and Markus Rickert, and Jürgen Steinmeyer, and Stefan Rehart, and Thomas Umscheid, and Markus Schönburg, and Ulf Müller-Ladner, and Klaus T Preissner, and Klaus W Frommer, and Elena Neumann
May 2000, Annals of the rheumatic diseases,
Copied contents to your clipboard!